| Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens ND Walter, SEM Born, GT Robertson, M Reichlen, C Dide-Agossou, ... Nature communications 12 (1), 2899, 2021 | 58 | 2021 |
| Efficacy and improved resistance potential of a cofactor-independent InhA inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ mouse model GT Robertson, VA Ektnitphong, MS Scherman, MB McNeil, D Dennison, ... Antimicrobial Agents and Chemotherapy 63 (4), 10.1128/aac. 02071-18, 2019 | 14 | 2019 |
| Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens. Nat Commun 12: 2899 ND Walter, SEM Born, GT Robertson, M Reichlen, C Dide-Agossou, ... | 10 | 2021 |
| Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408 J Liu, PB Lukka, VA Ektnitphong, KR Parmar, S Wagh, Y Lu, RB Lee, ... Bioorganic & Medicinal Chemistry Letters 112, 129934, 2024 | | 2024 |
| An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection V Ektnitphong, BRS Dias, PC Campos, MU Shiloh bioRxiv, 2024 | | 2024 |
| Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice EA Wynn, C Dide-Agossou, R Al Mubarak, K Rossmassler, V Ektnitphong, ... bioRxiv, 2024 | | 2024 |
